EODData

NASDAQ, JANX: Janux Therapeutics Inc

12 Feb 26 17:42
LAST:

13.13

CHANGE:
 0.02
OPEN:
13.10
HIGH:
13.48
ASK:
0.00
VOLUME:
1.18M
CHG(%):
0.15
PREV:
13.11
LOW:
13.02
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
12 Feb 2613.1013.4813.0213.131.18M
11 Feb 2613.1513.3112.7413.11792.2K
10 Feb 2613.2313.6113.0413.13665.8K
09 Feb 2613.0313.4512.7513.271.17M
06 Feb 2612.4513.3812.4213.071.77M
05 Feb 2613.2013.3612.1212.181.52M
04 Feb 2613.9613.9713.3113.331.54M
03 Feb 2613.9114.1613.3513.802.81M
02 Feb 2613.6414.0013.4413.991.09M
30 Jan 2613.8213.9613.4313.711.09M

PROFILE

Name:Janux Therapeutics Inc
About:Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer. Its clinical candidates include JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor that is in Phase 1 clinical trial for the treatment of various solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, renal cell carcinoma, small cell lung cancer, pancreatic ductal adenocarcinoma, and triple-negative breast cancer. Janux Therapeutics, Inc. has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. The company was incorporated in 2017 and is headquartered in San Diego, California.
Sector:Healthcare
Industry:Biotechnology
Address:10955 Vista Sorrento Parkway, San Diego, CA, United States, 92130
Website:https://www.januxrx.com
CUSIP:47103J105
CIK:0001817713
ISIN:US47103J1051
FIGI:BBG00ZHSKH11

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-21.38 
Forward P/E:-4.70 
PEG Ratio:-0.05 
Price to Sales:3,930.06 
Price to Book:0.86 
Operating Margin:-330.02 
Return on Assets:-0.11 
Return on Equity:-0.13 
EPS Ratio:-1.74 
Revenue:439.0K 
Shares:60.15M 
Market Cap:789.74M 

TECHNICAL INDICATORS

MA5:13.140.1%
MA10:13.271.1%
MA20:13.694.2%
MA50:14.268.6%
MA100:20.6657.4%
MA200:22.6972.8%
STO9:47.98
STO14:33.22
RSI14:31.90 
WPR14:-62.75
MTM14:-1.51
ROC14:-0.10 
ATR:0.68 
Week High:13.613.7%
Week Low:12.128.3%
Month High:15.4918.0%
Month Low:12.1272.8%
Year High:38.42192.6%
Year Low:12.128.3%
Volatility:23.24